Stocks and Investing
Stocks and Investing
Wed, May 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (VCYT) at Strong Buy with Decreased Target to $27 on, May 8th, 2024
Mike Matson of Needham, Maintained "Veracyte, Inc." (VCYT) at Strong Buy with Decreased Target from $33 to $27 on, May 8th, 2024.
Mike has made no other calls on VCYT in the last 4 months.
There are 2 other peers that have a rating on VCYT. Out of the 2 peers that are also analyzing VCYT, 0 agree with Mike's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mike
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Monday, April 15th, 2024
- Tejas Savant of "Morgan Stanley" Maintained at Sell with Decreased Target to $21 on, Monday, February 26th, 2024
Contributing Sources